Search

Russell A Ferlita

from Tampa, FL
Age ~81

Russell Ferlita Phones & Addresses

  • 9808 Armenia Ave, Tampa, FL 33612 (813) 930-6755 (813) 931-7061 (813) 931-7162
  • Brooksville, FL
  • Perry, FL
  • Westfield, NJ
  • Wayne, PA
  • Milltown, NJ
  • 9808 N Armenia Ave, Tampa, FL 33612 (813) 389-9978

Work

Position: Food Preparation and Serving Related Occupations

Education

Degree: Bachelor's degree or higher

Emails

Professional Records

License Records

Russell Angelo Ferlita

Address:
9808 N Armenia Ave, Tampa, FL 33612
License #:
47075 - Active
Category:
Engineers
Issued Date:
Aug 23, 1993
Effective Date:
Aug 23, 1993
Expiration Date:
Feb 28, 2019
Type:
Professional Engineer

Russell Rosario Ferlita

Address:
15302 Carrollton Ln, Tampa, FL 33624
License #:
1100016430
Category:
Engineers
Issued Date:
Jun 9, 2012
Effective Date:
Jun 9, 2012
Type:
Engineering Intern

Russell Rosario Ferlita

Address:
15302 Carrollton Ln, Tampa, FL 33624
License #:
77753 - Active
Category:
Engineers
Issued Date:
Jun 12, 2014
Effective Date:
Mar 13, 2015
Expiration Date:
Feb 28, 2019
Type:
Professional Engineer

Resumes

Resumes

Russell Ferlita Photo 1

President

View page
Location:
Tampa, FL
Industry:
Civil Engineering
Work:
Ferlita Engineering
President
Russell Ferlita Photo 2

Ph.d. Candidate At University Of South Florida

View page
Location:
Tampa/St. Petersburg, Florida Area
Industry:
Higher Education

Business Records

Name / Title
Company / Classification
Phones & Addresses
Russell A. Ferlita
Director, Vice President
New Florida Region Model "A" Restorers Club, Inc
Business Services at Non-Commercial Site · Nonclassifiable Establishments
1001 Rdg Ave, Clearwater, FL 33755
1650 47 Ave N, Saint Petersburg, FL 33714
Russell R Ferlita
Manager
STAGELIGHTS PERFORMING ARTS CENTER LLC
15301 Winterwind Dr, Tampa, FL 33624
Russell A. Ferlita
President, Director
Mini Mitre Corp
935 Sheila Lynn Ct, Dade City, FL 33523
Russell A. Ferlita
President, Director
Cedar Ridge Development Corp
935 Sheila Lynn Ct, Dade City, FL 33523
Russell A. Ferlita
President, Director
Custom Comfort Builders Corporation
1448 W Busch Blvd, Tampa, FL 33612
Russell Ferlita
Director
Windwalker Design Corporation
514 Lemon St, New Port Richey, FL 34652
Russell A. Ferlita
President, Director
FERLITA ENGINEERING, INC
PO Box 1162, Dade City, FL 33525
935 Sheila Lynn Ct, Dade City, FL 33523
2108 Moore Dr, Dade City, FL
Russell A. Ferlita
Director
FERLITA MOTOR COMPANY
7216 E 22 St Cswy, Tampa, FL 33619
4507 Dazzo Ave, Tampa, FL

Publications

Us Patents

Amorphous Form Of A Phosphoric Acid Salt Of A Dipeptidyl Peptidase-Iv Inhibitor

View page
US Patent:
7612072, Nov 3, 2009
Filed:
Sep 9, 2005
Appl. No.:
11/660722
Inventors:
Russell R. Ferlita - Westfield NJ, US
Robert M. Wenslow - Cream Ridge NJ, US
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
A61K 31/4985
US Classification:
514249, 544350
Abstract:
The present invention relates to a novel amorphous form of the dihydrogenphosphate salt of (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-α]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine of structural formula I as well as a process for its preparation, pharmaceutical compositions containing this novel form, and methods of use of the novel form and pharmaceutical compositions for the treatment of diabetes, obesity, and high blood pressure.

Synthesis And Crystalline Forms Of Npy5 Antagonist

View page
US Patent:
7700611, Apr 20, 2010
Filed:
Jul 24, 2006
Appl. No.:
11/988780
Inventors:
Russell R. Ferlita - Westfield NJ, US
Yuji Haga - Tsukuba, JP
Makoto Ishikawa - Ushiku, JP
Keisuke Kamei - Isesaki, JP
Shinji Kato - Nagoya, JP
Hisaki Kojima - Nagoya, JP
Aaron Moment - Edison NJ, US
Nobuaki Nonoyama - Chiryu, JP
Nobuya Satake - Okazaki, JP
Kazuki Shigemori - Anjyou, JP
Toshihiro Wada - Tsukuba, JP
Yaling Wang - Westfield NJ, US
Steven A. Weissman - Short Hills NJ, US
Robert M. Wenslow - Cream Ridge NJ, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
A61K 31/4355
C07D 491/048
US Classification:
514278, 546 15, 546116, 514302
Abstract:
The present invention relates to a process for producing crystalline trans-N-[1-(2-fluorophenyl)-S-pyrazoly]-3-ox-ospiro[6-azaisobenzofuran-1(3H),1′-cyclohexane]-4′-carboxamide and novel salts, hydrates and polymorphs thereof.

Crystalline Forms Of Mc4R Agonist And Process For Synthesis

View page
US Patent:
8129413, Mar 6, 2012
Filed:
Jun 23, 2006
Appl. No.:
11/921824
Inventors:
Ralph Calabria - East Brunswick NJ, US
Yu Cheng - Harleysville PA, US
Russell R. Ferlita - Westfield NJ, US
Ashkan Kamali - West Conshohocken PA, US
Jerry A. Murry - Jersey City NJ, US
David Mathre - Skillman NJ, US
Andrey V. Peresypkin - Cranford NJ, US
Karen Thompson - Lansdale PA, US
Jian Wang - Neshanic Station NJ, US
Robert M. Wenslow - Cream Ridge NJ, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
A61K 31/454
C07D 401/06
US Classification:
514326, 546208
Abstract:
The present invention relates to a process for producing N-{(1S)-1-[2-(1-{[(3S,4R)-1-tert-butyl-4-(2,4-difluorophenyl)pyrrolidin-3-yl]carbonyl}piperidin-4-yl)-5-chlorophenyl]ethyl}acetamide, and novel crystalline salts, hydrates, solvates, and polymorphic forms thereof.

Crystalline Forms Of An Inhibitor Of 11-Β-Hydroxysteroid Dehydrogenase Type 1

View page
US Patent:
8618112, Dec 31, 2013
Filed:
Dec 7, 2009
Appl. No.:
13/133516
Inventors:
Joseph E. Lynch - Plainfield NJ, US
Yuri Y. Bereznitski - South River NJ, US
Frederick T. Mattrey - Bridgewater NJ, US
Russell R. Ferlita - Tampa FL, US
Jinchu Liu - Edison NJ, US
Jungjun Yin - Green Brook NJ, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
A61K 31/41
A61K 31/4196
C07D 249/08
C07D 401/04
US Classification:
514256, 514331, 514340, 514364, 544333, 548131, 548167, 548203, 5482662
Abstract:
Novel crystalline salts of 3-[4-(3-ethanesulfonyl-propyl)-bicyclo[2. 2. 2]oct-1-yl]-4-methyl-5-(2-trifluoromethyl-phenyl)-4H-1,2,4-triazole are potent inhibitors of 11β-hydroxysteroid dehydrogenase Type 1 and are useful for the treatment of conditions associated with Metabolic Syndrome as well as cognitive impairment. The invention also relates to pharmaceutical compositions containing these novel salts, processes to prepare these salts and their pharmaceutical compositions as well as uses thereof for the treatment of Type 2 diabetes, hyperglycemia, obesity, dyslipidemia, hypertension, and cognitive impairment.

Hydrohalide Salts Of An Hiv Protease Inhibitor

View page
US Patent:
20030125336, Jul 3, 2003
Filed:
May 30, 2002
Appl. No.:
10/158630
Inventors:
Fred Fleitz - Franklin Park NJ, US
Daniel Petrillo - Hoboken NJ, US
Yaling Wang - Westfield NJ, US
Russell Ferlita - Milltown NJ, US
David Dubost - Collegeville PA, US
Joseph Armstrong - Westfield NJ, US
International Classification:
A61K031/496
C07D413/14
US Classification:
514/253100, 544/360000
Abstract:
Pharmaceutically acceptable hydrochloride and hydrobromide salts of Compound A are disclosed, wherein Compound A is of formula: Compound A and its hydrobromide and hydrochloride salts are HIV protease inhibitors useful for preventing or treating HIV infection, for delaying the onset of AIDS, and for treating AIDS. Pharmaceutical compositions employing the crystalline salts, and processes for making and using the crystalline salts are also disclosed.

Phosphoric Acid Salt Of A Dipeptidyl Peptidase-Iv Inhibitor

View page
US Patent:
20050032804, Feb 10, 2005
Filed:
Jun 23, 2004
Appl. No.:
10/874992
Inventors:
Stephen Cypes - Santa Clara CA, US
Alex Chen - Metuchen NJ, US
Russell Ferlita - Westfield NJ, US
Karl Hansen - Atlantic Highlands NJ, US
Ivan Lee - Piscataway NJ, US
Vicky Vydra - Fair Lawn NJ, US
Robert Wenslow - East Windsor NJ, US
International Classification:
A61K031/498
C07D487/04
US Classification:
514249000, 544350000
Abstract:
The dihydrogenphosphate salt of 4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro [1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine is a potent inhibitor of dipeptidyl peptidase-IV and is useful for the prevention and/or treatment of non-insulin dependent diabetes mellitus, also referred to as type 2 diabetes. The invention also relates to a crystalline monohydrate of the dihydrogenphosphate salt as well as a process for its preparation, pharmaceutical compositions containing this novel form and methods of use for the treatment of diabetes, obesity, and high blood pressure.

Novel Crystalline Salts Of A Dipeptidyl Peptidase-Iv Inhibitor

View page
US Patent:
20080227786, Sep 18, 2008
Filed:
Jan 12, 2005
Appl. No.:
10/585603
Inventors:
Russell R. Ferlita - Westfield NJ, US
Karl Hansen - Atlantic Highlands NJ, US
Vicky K. Vydra - Fair Lawn NJ, US
Yaling Wang - Westfield NJ, US
Christopher M. Lindemann - Loveland CO, US
International Classification:
A61K 31/4985
C07D 487/02
A61P 3/10
US Classification:
514249, 544350
Abstract:
Novel crystalline salts of (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-&agr; amine are potent inhibitors of dipeptidyl peptidase-IV and are useful for the treatment of non-insulin dependent (Type 2) diabetes mellitus. The invention also relates to pharmaceutical compositions containing these novel salts, processes to prepare these salts and their pharmaceutical compositions as well as uses thereof for the treatment of Type 2 diabetes.
Russell A Ferlita from Tampa, FL, age ~81 Get Report